The prevalence of vitamin D deficiency and associated factors in first-episode psychosis.
cognition
psychopathology
psychotic disorders
schizophrenia
vitamin D
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
12 Sep 2023
12 Sep 2023
Historique:
revised:
29
01
2023
received:
18
08
2022
accepted:
22
08
2023
medline:
13
9
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
aheadofprint
Résumé
Vitamin D deficiency is prevalent in people with established psychotic disorders, but less is known about vitamin D levels in people with first-episode psychosis (FEP). This study aimed to determine the prevalence of vitamin D deficiency in people with FEP and identify the factors associated with vitamin D status. This was a prospective cohort study nested within a randomized controlled trial, which included 37 young people with an FEP with minimal antipsychotic medication exposure. Twenty-four percent of participants were vitamin D deficient, and a further 30% were vitamin D insufficient. There was no association between vitamin D and demographic factors or clinical symptoms (positive, negative, general psychopathology and depressive symptoms) or cognition and functioning. However, vitamin D levels were associated with season of sampling. Considering the longer-term adverse effects associated with vitamin D deficiency, it is warranted to ensure this clinical population receives supplementation if indicated.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Morris family Philanthropic foundation
Organisme : University of Melbourne
Informations de copyright
© 2023 The Authors. Early Intervention in Psychiatry published by John Wiley & Sons Australia, Ltd.
Références
Albiñana, C., Boelt, S. G., Cohen, A. S., Zhu, Z., Musliner, K. L., Vilhjálmsson, B. J., & McGrath, J. J. (2021). Developmental exposure to vitamin D deficiency and subsequent risk of schizophrenia. Schizophrenia Research., 247, 26-32. https://doi.org/10.1016/j.schres.2021.06.004
Andreasen, N. C. (1989). The scale for the assessment of negative symptoms (SANS): Conceptual and theoretical foundations. British Journal of Psychiatry, 155(S7), 49-52. https://doi.org/10.1192/s0007125000291496
Crews, M., Lally, J., Gardner-Sood, P., Howes, O., Bonaccorso, S., Smith, S., Murray, R. M., di Forti, M., & Gaughran, F. (2013). Vitamin D deficiency in first episode psychosis: A case-control study. Schizophrenia Research, 150(2-3), 533-537. https://doi.org/10.1016/j.schres.2013.08.036
Cui, X., McGrath, J. J., Burne, T. H. J., & Eyles, D. W. (2021). Vitamin D and schizophrenia: 20 years on. Molecular Psychiatry., 26, 2708-2720. https://doi.org/10.1038/s41380-021-01025-0
De Paula, J. J., Malloy-Diniz, L. F., & Romano-Silva, M. A. (2016). Reliability of working memory assessment in neurocognitive disorders: A study of the digit span and Corsi block-tapping tasks. Revista Brasileira de Psiquiatria, 38(3), 262-263. https://doi.org/10.1590/1516-4446-2015-1879
Firth, J., Carney, R., Stubbs, B., Teasdale, S. B., Vancampfort, D., Ward, P. B., Berk, M., & Sarris, J. (2018). Nutritional deficiencies and clinical correlates in first-episode psychosis: A systematic review and meta-analysis. Schizophrenia Bulletin, 44(6), 1275-1292. https://doi.org/10.1093/schbul/sbx162
Fung, G. J., Steffen, L. M., Zhou, X., Harnack, L., Tang, W., Lutsey, P. L., Loria, C. M., Reis, J. P., & van Horn, L. V. (2012). Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20 y: The coronary artery risk development in young adults study. The American Journal of Clinical Nutrition, 96(1), 24-29. https://doi.org/10.3945/ajcn.112.036863
Garrido-Torres, N., Rocha-Gonzalez, I., Alameda, L., Rodriguez-Gangoso, A., Vilches, A., Canal-Rivero, M., Crespo-Facorro, B., & Ruiz-Veguilla, M. (2021). Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: A systematic review and meta-analysis. Psychological Medicine, 51(14), 2307-2320. https://doi.org/10.1017/S0033291721002853
Gaughran, F., Stringer, D., Wojewodka, G., Landau, S., Smith, S., Gardner-Sood, P., Taylor, D., Jordan, H., Whiskey, E., Krivoy, A., Ciufolini, S., Stubbs, B., Casetta, C., Williams, J., Moore, S., Allen, L., Rathod, S., Boardman, A., Khalifa, R., … McGrath, J. (2021). Effect of vitamin D supplementation on outcomes in people with early psychosis: The DFEND randomized clinical trial. JAMA Network Open, 4(12), e2140858. https://doi.org/10.1001/jamanetworkopen.2021.40858
Graham, K. A., Keefe, R. S., Lieberman, J. A., Calikoglu, A. S., Lansing, K. M., & Perkins, D. O. (2015). Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Interv Psychiatry, 9(5), 397-405. https://doi.org/10.1111/eip.12122
Holick, M. F. (1995). Environmental factors that influence the cutaneous production of vitamin D. The American Journal of Clinical Nutrition, 61(3), 638S-645S. https://doi.org/10.1093/ajcn/61.3.638S
Horton-French, K., Dunlop, E., Lucas, R. M., Pereira, G., & Black, L. J. (2021). Prevalence and predictors of vitamin D deficiency in a nationally representative sample of Australian adolescents and young adults. European Journal of Clinical Nutrition., 75, 1627-1636. https://doi.org/10.1038/s41430-021-00880-y
Lally, J., Ajnakina, O., Singh, N., Gardner-Sood, P., Stubbs, B., Stringer, D., di Forti, M., David, A. S., Smith, S., Murray, R. M., Howes, O. D., & Gaughran, F. (2019). Vitamin D and clinical symptoms in first episode psychosis (FEP): A prospective cohort study. Schizophr Res, 204, 381-388. https://doi.org/10.1016/j.schres.2018.08.011
Larson, M. K., Walker, E. F., & Compton, M. T. (2010). Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Review of Neurotherapeutics, 10(8), 1347-1359. https://doi.org/10.1586/ern.10.93
Morgan, V. A., McGrath, J. J., Jablensky, A., Badcock, J. C., Waterreus, A., Bush, R., Carr, V., Castle, D., Cohen, M., Galletly, C., Harvey, C., Hocking, B., McGorry, P., Neil, A. L., Saw, S., Shah, S., Stain, H. J., & Mackinnon, A. (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: Data from the second Australian national survey of psychosis. Psychological Medicine, 44(10), 2163-2176. https://doi.org/10.1017/s0033291713002973
Nerhus, M., Berg, A. O., Dahl, S. R., Holvik, K., Gardsjord, E. S., Weibell, M. A., Bjella, T. D., Andreassen, O. A., & Melle, I. (2015). Vitamin D status in psychotic disorder patients and healthy controls-the influence of ethnic background. Psychiatry Res, 230(2), 616-621. https://doi.org/10.1016/j.psychres.2015.10.015
Nowson, C. A., McGrath, J. J., Ebeling, P. R., Haikerwal, A., Daly, R. M., Sanders, K. M., Seibel, M. J., Mason, R. S., & Working Group of Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. (2012). Vitamin D and health in adults in Australia and New Zealand: A position statement. Medical Journal of Australia, 196(11), 686-687. https://doi.org/10.5694/mja11.10301
O'Donoghue, B., Mifsud, N. G., Tindall, R. M., Foote, L., Hartmann, J. A., Obst, K., Simmons, M. B., McGorry, P. D., & Killackey, E. (2020). Physical health assistance in early recovery of psychosis: Study protocol for a randomized controlled trial. Early Intervention in Psychiatry, 14(5), 587-593. https://doi.org/10.1111/eip.12884
Parker, J., Hashmi, O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N.-B., Clarke, A., & Franco, O. H. (2010). Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas, 65(3), 225-236. https://doi.org/10.1016/j.maturitas.2009.12.013
Pludowski, P., Holick, M. F., Grant, W. B., Konstantynowicz, J., Mascarenhas, M. R., Haq, A., Povoroznyuk, V., Balatska, N., Barbosa, A. P., Karonova, T., Rudenka, E., Misiorowski, W., Zakharova, I., Rudenka, A., Łukaszkiewicz, J., Marcinowska-Suchowierska, E., Łaszcz, N., Abramowicz, P., Bhattoa, H. P., & Wimalawansa, S. J. (2018). Vitamin D supplementation guidelines. The Journal of Steroid Biochemistry and Molecular Biology, 175, 125-135. https://doi.org/10.1016/j.jsbmb.2017.01.021
Pludowski, P., Holick, M. F., Pilz, S., Wagner, C. L., Hollis, B. W., Grant, W. B., Shoenfeld, Y., Lerchbaum, E., Llewellyn, D. J., Kienreich, K., & Soni, M. (2013). Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmunity Reviews, 12(10), 976-989. https://doi.org/10.1016/j.autrev.2013.02.004
Pramyothin, P., & Khaodhiar, L. (2010). Metabolic syndrome with the atypical antipsychotics. Current Opinion in Endocrinology, Diabetes and Obesity, 17(5), 460-466.
Rhoades, H. M., & Overall, J. E. (1988). The semistructured BPRS interview and rating guide. Psychopharmacology Bulletin, 24(1), 101-104.
Tsiglopoulos, J., Pearson, N., Mifsud, N., Allott, K., & O'Donoghue, B. (2021). The association between vitamin D and symptom domains in psychotic disorders: A systematic review. Schizophrenia Research, 237, 79-92. https://doi.org/10.1016/j.schres.2021.08.001
Valipour, G., Saneei, P., & Esmaillzadeh, A. (2014). Serum vitamin D levels in relation to schizophrenia: A systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab, 99(10), 3863-3872. https://doi.org/10.1210/jc.2014-1887
Zhu, J.-L., Luo, W.-W., Cheng, X., Li, Y., Zhang, Q.-Z., & Peng, W.-X. (2020). Vitamin D deficiency and schizophrenia in adults: A systematic review and meta-analysis of observational studies. Psychiatry Research, 288(112), 959. https://doi.org/10.1016/j.psychres.2020.112959